Formulation and Fill/Finish Solutions for Sterile Injectables
From Development to Delivery with Precision and Quality at Every Stage
Integrated Fill/Finish Expertise for Injectable Therapies
Afton Scientific provides fill/finish solutions tailored to support a broad range of sterile injectable products. With decades of experience, we streamline the progression from early development through to commercial production, supporting efficiency, sterility and regulatory compliance at every stage.
Our capabilities extend across biologics, small molecules and emerging modalities, including mRNA therapies, supporting clients in bringing innovative treatments to market with confidence.
Comprehensive Fill/Finish Solutions
Afton Scientific specialises in precision filling for sterile injectables, ensuring that every product maintains integrity from initial development through to final delivery.
From clinical supply to full-scale commercial manufacturing, we support flexibility, sterility and consistency in every fill.
Fill/Finish Capabilities include:
Vials
Supporting liquid products with advanced isolator-based filling.
Pre-Filled Syringes
Enhancing ease of use while reducing contamination risks.
Cartridges
Providing solutions for auto-injectors and pen systems.
Scalability and Seamless Process Integration
We simplify technology transfer and scale-up through:
- Streamlined Process Development
Reducing complexity to support efficient project execution. - Flexible Batch Sizes
Supporting clinical trials, commercial supply, and future growth. - Regulatory and Quality Alignment
Ensuring compliance with FDA, EMA, PMDA and global regulatory standards.
Our collaborative approach ensures that formulation development and filling processes are fully integrated, supporting improved efficiency and successful outcomes.
Expanding Capabilities: Looking Ahead
Expanding Capabilities: Today and Tomorrow
Afton Scientific continues to invest in advanced aseptic technologies to meet evolving industry requirements. Our expansion programmes focus on increasing sterile filling capacity and enhancing format flexibility for our partners.
• A new isolator-based filling line will increase overall throughput while supporting enhanced sterility assurance and contamination control.
• Expanded vial filling capacity supports both clinical and commercial-scale sterile injectable programmes.
• Future-ready capabilities for pre-filled syringes (PFS) and cartridges, enabling smooth transitions as products progress through lifecycle stages.